Chemotherapy-induced nausea and vomiting are among the most distressing side effects of anti-cancer treatment, particularly for those receiving highly emetogenic regimens such as anthracycline plus ...
Am J Health Syst Pharm. 2008;65(12):1180-1183. Ultimately, more formalized, high-quality, and clinically applicable studies are necessary to determine the safety of the parenteral combination of ...
Researchers from Japan found that a 5 mg dose of olanzapine, taken after chemotherapy, significantly reduces nausea and vomiting in breast cancer patients, while minimizing sedation and cutting costs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results